Skip to main content

Drug Recalls Topic Center

The Latest

News
01/15/2025
Rising Pharma Holding, Inc. has issued a voluntary nationwide recall of multiple lots of duloxetine delayed-release (DR) Capsules in various dosages.
Rising Pharma Holding, Inc. has issued a voluntary nationwide recall of multiple lots of duloxetine delayed-release (DR) Capsules in various dosages.
Rising Pharma Holding, Inc. has...
01/15/2025
Pharmacy Learning Network
News
01/15/2025
Amneal Pharmaceuticals LLC has initiated a voluntary recall of clobazam tablets, 10 mg, packaged in 30-tablet cartons (NDC 60687-423-21) distributed by American Health Packaging.
Amneal Pharmaceuticals LLC has initiated a voluntary recall of clobazam tablets, 10 mg, packaged in 30-tablet cartons (NDC 60687-423-21) distributed by American Health Packaging.
Amneal Pharmaceuticals LLC has...
01/15/2025
Pharmacy Learning Network
News
01/15/2025
The FDA has announced a nationwide recall of clonazepam orally disintegrating tablets in various strengths distributed by PAR Pharmaceutical and manufactured by Endo USA, Inc.
The FDA has announced a nationwide recall of clonazepam orally disintegrating tablets in various strengths distributed by PAR Pharmaceutical and manufactured by Endo USA, Inc.
The FDA has announced a...
01/15/2025
Pharmacy Learning Network
News
01/09/2025
Lupin Pharmaceuticals has issued a Class II recall of Levothyroxine sodium tablets, 75 mcg, due to impurity and degradation issues identified during stability testing, potentially affecting medication safety and efficacy
Lupin Pharmaceuticals has issued a Class II recall of Levothyroxine sodium tablets, 75 mcg, due to impurity and degradation issues identified during stability testing, potentially affecting medication safety and efficacy
Lupin Pharmaceuticals has issued...
01/09/2025
Pharmacy Learning Network
News
01/09/2025
AvKARE has issued a nationwide Class II recall of Nitrofurantoin capsules, USP, 100 mg, due to failed dissolution specifications, potentially impacting treatment effectiveness for urinary tract infections.
AvKARE has issued a nationwide Class II recall of Nitrofurantoin capsules, USP, 100 mg, due to failed dissolution specifications, potentially impacting treatment effectiveness for urinary tract infections.
AvKARE has issued a nationwide...
01/09/2025
Pharmacy Learning Network
News
01/08/2025
The FDA has issued a Class I recall of FORCE FOREVER 400mg Tablets, a dietary supplement for joint and bone health, due to undeclared pharmaceutical ingredients that pose serious health risks.
The FDA has issued a Class I recall of FORCE FOREVER 400mg Tablets, a dietary supplement for joint and bone health, due to undeclared pharmaceutical ingredients that pose serious health risks.
The FDA has issued a Class I...
01/08/2025
Pharmacy Learning Network
News
12/18/2024
Amerisource Health Services LLC is recalling tens of thousands of bottles of duloxetine delayed-release capsules because of an N-nitroso duloxetine impurity.
Amerisource Health Services LLC is recalling tens of thousands of bottles of duloxetine delayed-release capsules because of an N-nitroso duloxetine impurity.
Amerisource Health Services LLC...
12/18/2024
Pharmacy Learning Network
News
12/18/2024
American Regent Inc is recalling 10 lots of Venofer (iron sucrose) injection because of the potential for glass delamination of the vials.
American Regent Inc is recalling 10 lots of Venofer (iron sucrose) injection because of the potential for glass delamination of the vials.
American Regent Inc is recalling...
12/18/2024
Pharmacy Learning Network
News
12/18/2024
A Class I recall has been issued for dietary supplements marketed for male performance and energy by Boulla LLC and VitalityVita.
A Class I recall has been issued for dietary supplements marketed for male performance and energy by Boulla LLC and VitalityVita.
A Class I recall has been issued...
12/18/2024
Pharmacy Learning Network
News
12/06/2024
JR Watkins is recalling thousands of cooling menthol extra-strength pain relief patches because of deviations from Current Good Manufacturing Practice (CGMP) regulations.
JR Watkins is recalling thousands of cooling menthol extra-strength pain relief patches because of deviations from Current Good Manufacturing Practice (CGMP) regulations.
JR Watkins is recalling...
12/06/2024
Pharmacy Learning Network
News
12/06/2024
Neogen Corporation is recalling several lots of LiceOut nonfoaming shampoo because of violations of Current Good Manufacturing Practice (CGMP) regulations.
Neogen Corporation is recalling several lots of LiceOut nonfoaming shampoo because of violations of Current Good Manufacturing Practice (CGMP) regulations.
Neogen Corporation is recalling...
12/06/2024
Pharmacy Learning Network

Newsfeed

News
01/15/2025
Rising Pharma Holding, Inc. has issued a voluntary nationwide recall of multiple lots of duloxetine delayed-release (DR) Capsules in various dosages.
Rising Pharma Holding, Inc. has issued a voluntary nationwide recall of multiple lots of duloxetine delayed-release (DR) Capsules in various dosages.
Rising Pharma Holding, Inc. has...
01/15/2025
Pharmacy Learning Network
News
01/15/2025
Amneal Pharmaceuticals LLC has initiated a voluntary recall of clobazam tablets, 10 mg, packaged in 30-tablet cartons (NDC 60687-423-21) distributed by American Health Packaging.
Amneal Pharmaceuticals LLC has initiated a voluntary recall of clobazam tablets, 10 mg, packaged in 30-tablet cartons (NDC 60687-423-21) distributed by American Health Packaging.
Amneal Pharmaceuticals LLC has...
01/15/2025
Pharmacy Learning Network
News
01/15/2025
The FDA has announced a nationwide recall of clonazepam orally disintegrating tablets in various strengths distributed by PAR Pharmaceutical and manufactured by Endo USA, Inc.
The FDA has announced a nationwide recall of clonazepam orally disintegrating tablets in various strengths distributed by PAR Pharmaceutical and manufactured by Endo USA, Inc.
The FDA has announced a...
01/15/2025
Pharmacy Learning Network
News
01/09/2025
Lupin Pharmaceuticals has issued a Class II recall of Levothyroxine sodium tablets, 75 mcg, due to impurity and degradation issues identified during stability testing, potentially affecting medication safety and efficacy
Lupin Pharmaceuticals has issued a Class II recall of Levothyroxine sodium tablets, 75 mcg, due to impurity and degradation issues identified during stability testing, potentially affecting medication safety and efficacy
Lupin Pharmaceuticals has issued...
01/09/2025
Pharmacy Learning Network
News
01/09/2025
AvKARE has issued a nationwide Class II recall of Nitrofurantoin capsules, USP, 100 mg, due to failed dissolution specifications, potentially impacting treatment effectiveness for urinary tract infections.
AvKARE has issued a nationwide Class II recall of Nitrofurantoin capsules, USP, 100 mg, due to failed dissolution specifications, potentially impacting treatment effectiveness for urinary tract infections.
AvKARE has issued a nationwide...
01/09/2025
Pharmacy Learning Network
News
01/08/2025
The FDA has issued a Class I recall of FORCE FOREVER 400mg Tablets, a dietary supplement for joint and bone health, due to undeclared pharmaceutical ingredients that pose serious health risks.
The FDA has issued a Class I recall of FORCE FOREVER 400mg Tablets, a dietary supplement for joint and bone health, due to undeclared pharmaceutical ingredients that pose serious health risks.
The FDA has issued a Class I...
01/08/2025
Pharmacy Learning Network
News
12/18/2024
Amerisource Health Services LLC is recalling tens of thousands of bottles of duloxetine delayed-release capsules because of an N-nitroso duloxetine impurity.
Amerisource Health Services LLC is recalling tens of thousands of bottles of duloxetine delayed-release capsules because of an N-nitroso duloxetine impurity.
Amerisource Health Services LLC...
12/18/2024
Pharmacy Learning Network
News
12/18/2024
American Regent Inc is recalling 10 lots of Venofer (iron sucrose) injection because of the potential for glass delamination of the vials.
American Regent Inc is recalling 10 lots of Venofer (iron sucrose) injection because of the potential for glass delamination of the vials.
American Regent Inc is recalling...
12/18/2024
Pharmacy Learning Network
News
12/18/2024
A Class I recall has been issued for dietary supplements marketed for male performance and energy by Boulla LLC and VitalityVita.
A Class I recall has been issued for dietary supplements marketed for male performance and energy by Boulla LLC and VitalityVita.
A Class I recall has been issued...
12/18/2024
Pharmacy Learning Network
News
12/06/2024
JR Watkins is recalling thousands of cooling menthol extra-strength pain relief patches because of deviations from Current Good Manufacturing Practice (CGMP) regulations.
JR Watkins is recalling thousands of cooling menthol extra-strength pain relief patches because of deviations from Current Good Manufacturing Practice (CGMP) regulations.
JR Watkins is recalling...
12/06/2024
Pharmacy Learning Network
News
01/15/2025
Rising Pharma Holding, Inc. has issued a voluntary nationwide recall of multiple lots of duloxetine delayed-release (DR) Capsules in various dosages.
Rising Pharma Holding, Inc. has issued a voluntary nationwide recall of multiple lots of duloxetine delayed-release (DR) Capsules in various dosages.
Rising Pharma Holding, Inc. has...
01/15/2025
Pharmacy Learning Network
News
01/15/2025
Amneal Pharmaceuticals LLC has initiated a voluntary recall of clobazam tablets, 10 mg, packaged in 30-tablet cartons (NDC 60687-423-21) distributed by American Health Packaging.
Amneal Pharmaceuticals LLC has initiated a voluntary recall of clobazam tablets, 10 mg, packaged in 30-tablet cartons (NDC 60687-423-21) distributed by American Health Packaging.
Amneal Pharmaceuticals LLC has...
01/15/2025
Pharmacy Learning Network
News
01/15/2025
The FDA has announced a nationwide recall of clonazepam orally disintegrating tablets in various strengths distributed by PAR Pharmaceutical and manufactured by Endo USA, Inc.
The FDA has announced a nationwide recall of clonazepam orally disintegrating tablets in various strengths distributed by PAR Pharmaceutical and manufactured by Endo USA, Inc.
The FDA has announced a...
01/15/2025
Pharmacy Learning Network
News
01/10/2025
Older adults with weakened immune systems, such as organ transplant recipients on immunosuppressive medications, respond less robustly to respiratory syncytial virus (RSV) vaccines than their peers with normal immune function.
Older adults with weakened immune systems, such as organ transplant recipients on immunosuppressive medications, respond less robustly to respiratory syncytial virus (RSV) vaccines than their peers with normal immune function.
Older adults with weakened...
01/10/2025
Pharmacy Learning Network
News
01/09/2025
Lupin Pharmaceuticals has issued a Class II recall of Levothyroxine sodium tablets, 75 mcg, due to impurity and degradation issues identified during stability testing, potentially affecting medication safety and efficacy
Lupin Pharmaceuticals has issued a Class II recall of Levothyroxine sodium tablets, 75 mcg, due to impurity and degradation issues identified during stability testing, potentially affecting medication safety and efficacy
Lupin Pharmaceuticals has issued...
01/09/2025
Pharmacy Learning Network
News
01/09/2025
AvKARE has issued a nationwide Class II recall of Nitrofurantoin capsules, USP, 100 mg, due to failed dissolution specifications, potentially impacting treatment effectiveness for urinary tract infections.
AvKARE has issued a nationwide Class II recall of Nitrofurantoin capsules, USP, 100 mg, due to failed dissolution specifications, potentially impacting treatment effectiveness for urinary tract infections.
AvKARE has issued a nationwide...
01/09/2025
Pharmacy Learning Network
News
01/08/2025
The FDA has issued a Class I recall of FORCE FOREVER 400mg Tablets, a dietary supplement for joint and bone health, due to undeclared pharmaceutical ingredients that pose serious health risks.
The FDA has issued a Class I recall of FORCE FOREVER 400mg Tablets, a dietary supplement for joint and bone health, due to undeclared pharmaceutical ingredients that pose serious health risks.
The FDA has issued a Class I...
01/08/2025
Pharmacy Learning Network
News
12/18/2024
Amerisource Health Services LLC is recalling tens of thousands of bottles of duloxetine delayed-release capsules because of an N-nitroso duloxetine impurity.
Amerisource Health Services LLC is recalling tens of thousands of bottles of duloxetine delayed-release capsules because of an N-nitroso duloxetine impurity.
Amerisource Health Services LLC...
12/18/2024
Pharmacy Learning Network
News
12/18/2024
American Regent Inc is recalling 10 lots of Venofer (iron sucrose) injection because of the potential for glass delamination of the vials.
American Regent Inc is recalling 10 lots of Venofer (iron sucrose) injection because of the potential for glass delamination of the vials.
American Regent Inc is recalling...
12/18/2024
Pharmacy Learning Network
News
12/18/2024
A Class I recall has been issued for dietary supplements marketed for male performance and energy by Boulla LLC and VitalityVita.
A Class I recall has been issued for dietary supplements marketed for male performance and energy by Boulla LLC and VitalityVita.
A Class I recall has been issued...
12/18/2024
Pharmacy Learning Network